Medicared For All Logo

Kevin Kim in San Francisco, California

Home California San Francisco

Kevin Kim has Hematology/oncology as his primary medical specialty. Their primary office is: 2100 Webster St in San Francisco, California.

They're a part of the: San Francisco Oncology Associates Medical Group Inc medical group which has around 3 members. You can call their office at 415-885-8600 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Illinois College Of Med (chi/peor/rock/chm-urb) and graduated in 1995 (around 29 years of experience). They are listed as doing telehealth appointments.


Kevin Kim Office Phone and Directions

Kevin Kim
San Francisco Oncology Associates Medical Group Inc
2100 Webster St
San Francisco, California 94115
415-885-8600


Patient Ratings
Please rate your experience with Kevin Kim below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 415-885-8600


Enter a starting address:


Healthcare Info for Kevin Kim

Medical School: University Of Illinois College Of Med (chi/peor/rock/chm-urb)
Graduation Year: 1995
The Primary Medical Specialty for Kevin Kim is listed as: Hematology/oncology
Approximate Years of Experience: 29
PAC (PECOS ID)#: 5395861769
NPI #: 1851485056
NPI Created On: 10/03/2006
NPI Last Updated Listed as: 02/12/2015
Primary Taxonomy Code: 207RX0202X
License Number:
L4495
Listed Gender: Male

Procedures, Services, Charges


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Complete blood cell count (red cells, white blood cell, platelets), automated test
  3. Vaccine for influenza for injection into muscle
  4. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  5. Infusion of chemotherapy into a vein up to 1 hour
  6. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  7. New patient office or other outpatient visit, typically 30 minutes
  8. New patient office or other outpatient visit, typically 45 minutes
  9. Established patient office or other outpatient visit, typically 10 minutes
  10. Established patient office or other outpatient visit, typically 15 minutes
  11. Established patient office or other outpatient, visit typically 25 minutes
  12. Physician telephone patient service, 5-10 minutes of medical discussion
  13. Physician telephone patient service, 11-20 minutes of medical discussion
  14. Administration of influenza virus vaccine
  15. Injection, denosumab, 1 mg
  16. Infusion, normal saline solution, 250 cc
  17. Injection, ipilimumab, 1 mg
  18. Injection, pembrolizumab, 1 mg
  19. Injection, nivolumab, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788751685

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788751687

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: ERLEADA

Associated Drug #2: 59676-600-12

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: BALVERSA

Name Of Drug #3: 59676-030-56


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788751689

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788751691

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017153

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $32

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801648635

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ZEJULA

Open Associated Drug #1: 69656-103-90


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832184029

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $24

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783673075

Being Disputed:: No

Product Related: No


Payments Total: $21

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783415023

Being Disputed:: No

Product Related: No


Payments Total: $21

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783415061

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Hematology/oncology Professionals in San Francisco

400 Parnassus Ave
San-francisco, CA
Ucsf Medical Group Business Services

505 Parnassus Ave
San-francisco, CA
Ucsf Pediatrics Associates

2200 Ofarrell St
San-francisco, CA
Permanente Medical Group Inc

2238 Geary Blvd
San-francisco, CA
Permanente Medical Group Inc

2238 Geary Blvd
San-francisco, CA
Permanente Medical Group Inc

1001 Potrero Ave
San-francisco, CA
University Of California Sfgh Medical Group

Providers in San Francisco Oncology Associates Medical Group Inc

1.Kevin Kim

2100 Webster St
San Francisco Ca 94115-2378
San Francisco Oncology Associates Medical Group Inc
Hematology/oncology

2.Alan Kramer

2100 Webster St
San Francisco Ca 94115-2378
San Francisco Oncology Associates Medical Group Inc
Hematology/oncology

3.Wei Wang Md

2100 Webster St
San Francisco Ca 94115-2378
San Francisco Oncology Associates Medical Group Inc
Medical Oncology

View all 3 members of San Francisco Oncology Associates Medical Group Inc medical group